SYSTEM LUPUS ERYTHEMATOSUS(SLE)
Clinical trials for SYSTEM LUPUS ERYTHEMATOSUS(SLE) explained in plain language.
Never miss a new study
Get alerted when new SYSTEM LUPUS ERYTHEMATOSUS(SLE) trials appear
Sign up with your email to follow new studies for SYSTEM LUPUS ERYTHEMATOSUS(SLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell therapy hopes to tame tough lupus cases
Disease control Not yet recruitingThis study tests a new treatment called ACE1831 for people with moderate to severe lupus that hasn't responded to other therapies. ACE1831 uses immune cells from healthy donors to help control the disease. The study will check if the treatment is safe and if it can reduce lupus s…
Matched conditions: SYSTEM LUPUS ERYTHEMATOSUS(SLE)
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 26, 2026 07:09 UTC
-
New lupus drug combo enters first human tests
Disease control Not yet recruitingThis early study tests a new drug called YKST02, given alone or with another drug (YK012), in 30 adults with active or hard-to-treat lupus. The main goal is to see if the treatment is safe and tolerable. Researchers will also look for early signs that it helps control the disease…
Matched conditions: SYSTEM LUPUS ERYTHEMATOSUS(SLE)
Phase: PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 18, 2026 12:11 UTC